eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Shire Pharmaceuticals Limited
Hampshire International Business Park, Chineham, Basingstoke, Hampshire , RG24 8EP
Telephone: +44 (0)1256 894 000
WWW: http://www.shire.com
Medical Information Direct Line: 0800 055 6614
Medical Information e-mail: medinfoUK@shire.com
Customer Care direct line: +44 (0)1256 894 107

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/09/2010
PIL Reminyl XL 8mg, 16mg and 24mg prolonged release capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to Further Information section
Updated on 03/06/2010 and displayed until 07/09/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
Updated on 16/10/2009 and displayed until 03/06/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/08/2008 and displayed until 16/10/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change of active ingredient
  • Change to how the medicine works
  • Change to Further Information section
  • Change due to user-testing of patient information
  • Change to date of revision
  • Change of contra-indications
  • Change to drug interactions
  • Change to dosage and administration
Updated on 13/06/2008 and displayed until 22/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/09/2007 and displayed until 13/06/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 14/07/2006 and displayed until 25/09/2007
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to side-effects
  • Change to Further Information section
Updated on 10/06/2005 and displayed until 14/07/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  galantamine hydrobromide